Long-term toxicity of antischistosomal drugs: summary and perspectives

In addition to the papers presented at the workshop, there were also discussion periods following the presentations and concluding the whole workshop. The various parts in the present section represent summaries of the different discussions that took place at the end of the workshop, except for the first part, which reports on drugs currently used in the treatment of schistosomiasis and makes recommendations for developing new and better drugs. The other parts in this section present the discussions and recommendations dealing with these areas: epidemiology, infected animal studies, in vitro and in vivo test correlations, and benefit vs. risk correlation. The author of each paper served as a rapporteur for these discussion sessions.